Prenetics Global Ltd (PRE)
4.81
-0.07
(-1.43%)
USD |
NASDAQ |
Nov 14, 16:00
4.49
-0.32
(-6.65%)
After-Hours: 20:00
Prenetics Global Total Assets (Quarterly): 233.31M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 233.31M |
| March 31, 2024 | 243.59M |
| December 31, 2023 | 254.17M |
| September 30, 2023 | 276.41M |
| June 30, 2023 | 280.84M |
| March 31, 2023 | 291.04M |
| Date | Value |
|---|---|
| December 31, 2022 | 312.13M |
| September 30, 2022 | 269.60M |
| June 30, 2022 | 278.24M |
| March 31, 2022 | 169.58M |
| December 31, 2021 | 148.51M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
148.51M
Minimum
Dec 2021
312.13M
Maximum
Dec 2022
250.67M
Average
269.60M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Sino Biopharmaceutical Ltd | 9.177B |
| HUTCHMED (China) Ltd | 1.261B |
| Pharmaron Beijing Co Ltd | 3.058B |
| Regencell Bioscience Holdings Ltd | 8.438M |
| Uni-Bio Science Group Ltd | 62.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 42.30M |
| Shareholders Equity (Quarterly) | 188.24M |
| Current Ratio | 2.055 |